Related Experiment Videos
Immunorestorative effect of thymostimulin on surgery immunodepression: experimental model
J M García-Lechuz1, M Navarro, M J Morandeira
1Department of Surgery, University of Zaragoza, Spain.
Summary
This study investigated how two drugs, Inmunoferón and thymostimulin, affect immune recovery after small bowel surgery in rats. Thymostimulin showed promise in restoring immune function and skin graft rejection markers post-surgery.
Area of Science:
- Immunology
- Surgical Research
- Pharmacology
Background:
- Small bowel surgical resection can lead to significant immunodepression.
- Assessing immune restoration post-surgery is crucial for patient recovery.
- CD4/CD8 index changes and skin allograft rejection are indicators of immune status.
Purpose of the Study:
- To evaluate the immunorestorative effects of Inmunoferón and thymostimulin.
- To determine the drugs' ability to counteract surgery-induced immunodepression.
- To analyze the impact on skin allograft rejection and CD4/CD8 lymphocyte ratios.
Main Methods:
- 120 Wistar-Furth rats underwent surgical procedures with or without enterectomy.
- Animals received placebo, Inmunoferón, or thymostimulin.
- Skin graft rejection and spleen CD4/CD8 lymphocyte subpopulations were assessed.
Main Results:
- Thymostimulin stimulated skin graft rejection signs post-surgery.
- Thymostimulin prevented the decrease in the CD4/CD8 index in spleen tissue.
- Both drugs were evaluated for their immunorestorative potential.
Conclusions:
- Thymostimulin demonstrates immunorestorative properties following small bowel resection.
- The drug aids in normalizing immune parameters and graft rejection timelines.
- Further research into thymostimulin's clinical application in surgical recovery is warranted.